With multidrug-resistant cases of tuberculosis increasing globally, better antibiotic drugs and novel drug targets are becoming an urgent need. Traditional b-lactam antibiotics that inhibit D,D-transpeptidases are not effective against mycobacteria, in part because mycobacteria rely mostly on L,Dtranspeptidases for biosynthesis and maintenance of their peptidoglycan layer. This reliance plays a major role in drug resistance and persistence of Mycobacterium tuberculosis (Mtb) infections. The crystal structure at 1.7 Å resolution of the Mtb L,D-transpeptidase Ldt Mt2 containing a bound peptidoglycan fragment, reported here, provides information about catalytic site organization as well as substrate recognition by the enzyme. Based on our structural, kinetic, and calorimetric data, we propose a catalytic mechanism for Ldt Mt2 in which both acyl-acceptor and acyl-donor substrates reach the catalytic site from the same, rather than different, entrances. Together, this information provides vital insights to facilitate development of drugs targeting this validated yet unexploited enzyme.
INTRODUCTION
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (Mtb) are emerging at alarming rates (Fauci, 2008) . A possible reason for this is poor patient compliance with existing treatments, which require multiple drugs to be taken daily for at least 6 months (Medical Section of the American Lung Association, 1997) to eliminate the resilient $1% of bacilli, commonly known as persisters (Jindani et al., 2003; Lewis, 2007) . Any strategy aimed at shortening duration of tuberculosis therapy must be effective in eliminating the persisters. Mtb persists in the lungs of infected individuals in a slow-growing, nonreplicating dormant state in which the bacillus is resistant to the host immune response and is transiently tolerant of antibiotics (Betts et al., 2002; Bishai, 2000) . Mtb persisters extracted from lung lesions show morphological changes similar to those observed in bacilli that are subject to nutrient starvation or anaerobic stress (Betts et al., 2002) . These changes involve, among other physiologic alterations, the remodeling of the Mtb peptidoglycan layer (Lavollay et al., 2008) , a vital layer consisting of an elaborate network of peptidoglycan chains with crosslinked peptide stems.
Formation of the most common type of crosslink, the (D,D) 4/3 linkage (Figure 1A, top) , is catalyzed by the D,D-transpeptidase activity of enzymes commonly referred to as penicillin binding proteins. These enzymes catalyze the transfer of the peptide bond between the fourth residue (D chiral center) and the fifth residue of a pentapeptide donor stem to a side-chain amide group (also a D chiral center) at the third residue of an adjacent acceptor stem (usually a diamino acid). A second type of crosslink, the (L,D) 3/3 linkage (Figure 1A, bottom) , is catalyzed by L,D-transpeptidases such as the one studied here. These enzymes transfer the peptide bond between the third residue (L chiral center) of a tetrapeptide donor stem to the side-chain amide group of the third residue (D chiral center) of an adjacent acceptor stem. In both types of transpeptidases, the catalysis proceeds by a two-step mechanism: acylation of the enzyme by the penultimate peptide of the donor stem with the release of the stem C-terminal residue, followed by deacylation of this acyl-enzyme intermediate by an acceptor stem.
The 3/3 linkages were first identified in 1974 by Wietzerbin et al. in the peptidoglycan of mycobacteria (Wietzerbin et al., 1974) , but their significance and biosynthetic pathway remained unknown until recently, when their predominance in Mtb was demonstrated, and Ldt Mt1 (or MT0125, the product of gene Rv0116c) was identified as an L,D-transpeptidase that generates 3/3 linkages (Lavollay et al., 2008) . Frequently associated with virulence and b-lactam resistance, predominance of 3/3 linkage has been observed in spontaneous mutation of Enterococcus faecium (Mainardi et al., 2005) , in other mycobacteria M. abscessus (Lavollay et al., 2011) , and in the spore-forming bacteria Clostridium difficile (Peltier et al., 2011) .
Recently, another 3/3 L,D-transpeptidase, Ldt Mt2 (MT2594, the product of gene Rv2518c), was characterized in Mtb (Gupta et al., 2010 ). An Mtb strain lacking Ldt Mt2 loses virulence and has attenuated growth during the chronic phase of the disease (Gupta et al., 2010) . In addition, this strain is more susceptible to the therapeutic combination of amoxicillin and clavulanic acid, suggesting that the (3/3) L,D-transpeptidase activity is a major contributor to b-lactam resistance. It was also shown that a vaccine utilizing an M. bovis BCG strain that overexpresses L,D-transpeptidases has enhanced protective efficacy against Mtb persisters (Nolan and Lamichhane, 2010) , suggesting that the higher degree of 3/3 linkages resulting from the overexpression of the enzyme better represents the peptidoglycan layer of Mtb persisters.
Despite the obvious significance of L,D-transpeptidases in Mtb growth and virulence, to our knowledge, no structural or binding information exists for the five members of this class of Mtb enzymes identified to date (Gupta et al., 2010) . Here, we present the characterization of the extramembrane portion of Ldt Mt2 (ex-Ldt Mt2 ), including the determination of its structure at 1.7 Å resolution. Ex-Ldt Mt2 is composed of two domains: an N-terminal immunoglobulin-like domain, and a C-terminal catalytic ErfK/YbiS/YhnG domain (Pfam accession number PF03734). Based on this structure, comparative modeling of the identified Mtb homologs indicates that the N-terminal domain fold and the enzyme's overall conformation distinguish this group from other structurally characterized ErfK/YbiS/YhnG domain-containing proteins such as Bacillus subtilis ykuD (Bielnicki et al., 2006) and E. faecium L,D-transpeptidase Ldt fm (Biarrotte-Sorin et al., 2006) . The catalytic site of Ldt Mt2 , located at the entrance of a narrow tunnel connecting two cavities that are open to the solvent, is similar to that observed in Ldt fm (Biarrotte-Sorin et al., 2006) . Unexpectedly, the crystal structure shows the presence of a fragment of the peptidoglycan of the expression host (E. coli) in the catalytic site of the enzyme. Until now, to our knowledge, no related L,D-transpeptidase has been structurally characterized with a bound peptidoglycan fragment. Ldt Mt2 recognizes the peptidoglycan (acyl-donor-like) using residues located in both cavities, including the catalytic residues Cys354 and His336. The observed mode of binding of this short peptidoglycan fragment led us to propose a catalytic mechanism for these transpeptidases that differs from that previously posited by Biarrotte-Sorin et al. (2006) .
Kinetic measurements show that Ldt Mt2 has residual hydrolase activity toward certain b-lactams. Isothermal titration calorimetry (ITC) experiments show that the carbapenems (Bonfiglio et al., 2002) , imipenem and meropenem, bind only the catalytically active enzyme, and they do so with apparent submicromolar affinities. The structural, biochemical, and thermodynamic data presented here provide vital information about the interactions of the enzyme with its substrates and inhibitors that will help advance this unexploited enzyme into a target for the design of novel compounds for the treatment of Mtb infections.
RESULTS

Ex-Ldt Mt2 Crystal Structure
The extramembrane portion of the L,D-transpeptidase from Mtb, Ldt Mt2 (ex-Ldt Mt2 , residues 120-408), was cloned and expressed in E. coli. A crystal of a seleno-methionine (SeMet) derivative of ex-Ldt Mt2 was used to determine the structure using multiple anomalous dispersion (MAD) methods. The structure was refined to a final R work of 0.19 and an R free of 0.23 using diffraction data collected from a di-m-Iodo-bis[ethylenediamine]-di-Pt [II] (PIP) derivative crystal ( Figure 1B ; Table 1 ; see Figure S1 available online), which had the best diffraction among all the crystals tested (1.7 Å resolution). Crystals of ex-Ldt Mt2 belong to the orthorhombic space group I2 1 2 1 2 1 and contain two monomers (A and B) in the asymmetric unit. These two molecules do not correspond to a physiological dimer because ex-Ldt Mt2 behaves as a monomer in solution, as determined by size exclusion chromatography (data not shown). In addition, areas buried by the two possible dimers in the crystal asymmetric unit, 810 and 1,360 Å 2 , are not consistent with a dimer stable in solution (Krissinel, 2011) . A portion of the N-terminal region of ex-Ldt Mt2 , spanning residues 122-132, is observed only in monomer B with low occupancy (50%) and disconnected from the bulk of the fold. Amino acids from 150 to 407 are observed in both monomers of the crystal asymmetric unit with an rmsd of 0.31 Å between the aligned 258 Ca atoms of monomers A and B. Each monomer consists of two globular domains: an N-terminal domain (residues 150-250) folded as an antiparallel b barrel resembling an immunoglobulin domain (IgD) (Amzel and Poljak, 1979) ; and a C-terminal catalytic domain (CD; residues 254-407), consisting of a b sandwich with two mixed b sheets characteristic of the ErfK/YbiS/YhnG fold (Bielnicki et al., 2006) . A short linker (residues 251-253) joins the two domains ( Figure 1B) . A small (Amzel and Poljak, 1979) : the interstrand loops are unusually long, including a three-turn helix (a1) in the loop connecting strands b 3 and b 4 . In the refined structure, PIP was found to have reacted with solvent-exposed Nd atoms of histidine residues and with sulfur atoms of methionine residues (His214 in monomer A, and Met153, Met157, Met237, and His347 in both monomers) to form five (four in monomer B) iodo-Pt(II) ethylenediamine adducts ( Figure S1 ) (O'Halloran et al., 1987) .
Active Site A two-step enzymatic mechanism resembling that of D,D-transpeptidases was proposed for the ErfK/YbiS/YhnG-fold family of transpeptidases, except that the catalytic serine of D,D-transpeptidases is replaced by an absolutely conserved cysteine residue (Mainardi et al., 2007) Top view shows domain distribution of Ldt Mt2 . The ex-Ldt Mt2 protein construct used in this work is indicated by a dashed red box. Bottom view presents sequence alignment among aa 138-408 of Ldt Mt2 , Ldt MT1 , Ldt fm , and other Ldt Mt2 homologs in Mtb. The observed secondary structure is indicated above the corresponding residues. Identical residues are white with red background; regions scoring higher than 70% using a Risler's similarity scoring matrix (Risler et al., 1988) are boxed with red letters. Residues involved in binding and catalysis are labeled: the conserved motif is indicated with green marks and the rest with pink marks. Stars label main catalytic residues, and ovals label substrate recognition residues. The figure was made using the web server ESPript (http://espript.ibcp.fr/ESPript/ESPript/). three residues (underlined letters) analogous to the catalytic triad of cysteine proteases: a cysteine, a histidine, and a third residue that accept a hydrogen (H) bond from the histidine stabilizing the competent imidazole tautomer (Bielnicki et al., 2006; Dodson and Wlodawer, 1998) .
In ex-Ldt Mt2 , those catalytic residues, His336, Ser337, and Cys354, reside under a flap formed by a long insert (residues 299-323) that is not part of the canonical ErfK/YbiS/YhnG fold (Bielnicki et al., 2006) . This insert, strand b 15 , loop L F , and strand b 16 , folds over the b sheet formed by strands b 17 , b 18 , and b 19 (residues 324-357). The closed flap creates two large cavities (vestibules) connected by a narrow tunnel. These cavities are open to solvent: one at the end of the molecule, and the other at the interface between the CD and IgD ( Figure 1C , outer and inner cavities, respectively). Strand b 16 (residues 318-323), the C-terminal end of b 18 (residues 336 and 337), the loop Lc (residues 338-352), and the strand b 19 (residues 353-357) line the outer cavity ( Figure 1D ). The residues of the conserved motif ( Figure 2 ) are readily accessible through the outer cavity, with the catalytic residues located deep within it. With the exceptions of His336 and Ser337 (both in b 18 ), the conserved motifs extend through the end of loop Lc and strand b 19 . Ser351, His352, and Gly353 are located in loop Lc, whereas Cys354 and Asn356 in strand b 19 ( Figure 1D ). Other highly conserved residues in similar sequences of Gram-positive bacteria, Tyr318 and Gly332 in Ldt Mt2 (Figure 2) , are located at the inner cavity. Tyr318 and Met303 line the internal side of the flap and, together with Cys354, form the walls of the narrow tunnel. His336 and His352 flank the tunnel at the outer cavity ( Figure 1D ). The carbonyl group of Ser337 accepts an H bond from the Nd of His336 (2.8 Å ). This H bond stabilizes the tautomer of His336 protonated at Nd.
Comparison of Ldt Mt2 with Mtb Paralogs
The presence of five genes in Mtb that code for proteins with potential L,D-transpeptidase activity has been reported (Gupta et al., 2010) . Of these proteins, only Ldt Mt1 (Lavollay et al., 2008) and Ldt Mt2 (Gupta et al., 2010) have been shown to be functional L,D-transpeptidases. The multiple alignment of Ldt Mt2 with the other Mtb proteins shows pairwise sequence identities ranging from 33% to 45% (Figure 2 ), suggesting a high structural similarity of these proteins to ex-Ldt Mt2 . Comparative models of these proteins were built using Ldt Mt2 as a template (Figure 3 ). The overall fold of the IgD is conserved among these proteins. Three homologs, MT0202 (also know as Rv0192, 45% identity with Ldt Mt2 ), Ldt Mt1 (36%), and MT1477 (Rv1433, 33%), have a short loop connecting strands b 7 and b 10 and lack strands b 8 and b 9 of the ex-Ldt Mt2 IgD (Figures 2 and 3A) . The bulk of the CD has little variation among homologs: MT0501 (Rv0483, 34%) has the shortest loop L F among the five proteins, and MT1477 shows an 18-residue insertion after b 12 . The CTSDs of these homologs, however, show significant differences with Ldt Mt2 . The only exception is MT0501, which contains a CTSD of the same size and features as Ldt Mt2 . MT1477 and Ldt Mt1 completely lack this subdomain, and MT0202 has a significantly shortened version. Most of the motif residues (Figure 2 ) are conserved in these proteins, with the exception of the replacement of His 352 (Ldt Mt2 numbering; Figure 2 ) by an asparagine in MT0501. In the neighborhood of the active site, a methionine in MT0501 replaces the highly conserved Trp340 of Ldt Mt2 (Figures 2 and 3B ).
Peptidoglycan Fragment
Electron density not belonging to protein residues was present in the catalytic site of the SeMet and the PIP derivative crystals. This density, longer and more branched than either a succinic acid or a PEG molecule from the crystallization media, was interpreted as belonging to a dipeptide fragment of a muropeptide stem, probably a fragment of the E. coli peptidoglycan bound from the lysis supernatant and carried through the purification process. Ex-Ldt Mt2 probably recognizes common features between its physiological substrate and a muropeptide of E. coli. The peptidoglycan of Mtb contains muropeptides composed of an N-acetylglucosamine joined by a b (1-4)-glycosidic bond to an N-acetylmuramic acid decorated with four or five amino acid-long peptide stems ( (Barreteau et al., 2008) . The electron density, 14 Å in length, broadens at three places that correspond to carboxylates of the peptidoglycan ( Figures 4A and S2) . The broadest section, at the center of the catalytic site, is connected by narrow zigzag densities to two broad densities located at the tunnel entrances across from the active site tunnel. Based on the separation and size of these features, a g-D-Glu-m-A 2 pm dipeptide was built into this electron density ( Figure 4A ), with the terminal peptide L chiral center placed near the catalytic His336 and the D chiral center in the inner cavity of the tunnel, H bonded by Tyr318 and mainchain carboxyl of Gly332. The SH group of Cys354 is 4.6 Å from the carboxylate group of the dipeptide A 2 pm moiety (Figure 4A) . This carboxylate makes H bonds with the Nε of His336 and the Nd1 of Asn356, both residues of the conserved motif (Figure 2) . The g-D-Glu-m-A 2 pm dipeptide may correspond to the second and third peptide moieties of a peptidoglycan stem.
Chemical Modification of Cys354 in the Absence of Ligand
During the structural analysis, several of the structures of different native crystal forms showed modifications of Cys354 by buffer components or molecular oxygen (Figures 4B and 4C; Table S1 ). When b-mercaptoethanol (BME) is present, a disulfide bridge is formed between the Sg of Cys354 and BME ( Figure 4B ). The rest of the molecule remains unperturbed (rms 0.17 Å for 524 Cas of the crystal asymmetric unit). In protein crystals without endogenous ligand (obtained by purifying the protein under denaturing conditions; see Supplemental Experimental Procedures), Cys354 is in its sulfenic acid form (Figure 4C ). The rest of the structure, including the active site, does not show significant changes (rms 0.23 Å for 524 Cas of the crystal asymmetric unit). L,D-transpeptidases. Adducts of these carbapenems to Ldt fm (Mainardi et al., 2007) , Ldt Mt1 (Lavollay et al., 2008) , and Ldt Mt2 (Gupta et al., 2010) were identified using mass spectrometry.
Binding of Carbapenems to
To characterize direct binding of imipenem and meropenem to Ldt Mt2 in the absence of enzymatic activity, we performed ITC using a catalytically inactive mutant C354A. Surprisingly, no heat of complex formation was observed with the mutant protein with either imipenem ( Figure 6A ) or meropenem (data not shown) at ligand concentrations up to the millimolar range. In contrast, ITC experiments with the wild-type ex-Ldt Mt2 show strong binding of both carbapenems to the enzyme ( Figures 5C and 5D ).
Lack of binding by the C354A mutant is not due to a large structural change: the crystal structure of the mutant ( Figure 6B ; Table S1 ) shows no significant changes with respect to the wildtype (rmsd of 0.26 Å for 516 Ca atoms of the asymmetric unit). The absence of a thiol group at the residue 354 slightly widens the narrowest section of the tunnel, producing only minor disturbances in other binding site residues, not enough change to explain the lack of binding ( Figure 6B ).
Imipenem has approximately 17 times higher affinity for the enzyme than meropenem, which have been shown effective in combination with clavulanate for inhibit Mtb BlaC (Hugonnet et al., 2009) (Figures 5C and 5D Table S1 for structure determination statistics of the BME-adduct and oxidized forms. See also Figure S2 for a stereo view of an omit map.
to Ldt Mt2 is exothermic, the same reaction with meropenem is endothermic ( Figures  5C and 5D ). The meropenem-positive DS of binding, a consequence of its large hydrophobic surface area, partially compensates for the unfavorable enthalpic contribution. In addition to meropenem and imipenem, a potent b-lactamase inhibitor, clavulanic acid, was tested as a ligand of ex-Ldt Mt2 . ITC experiments did not detect binding by this compound to wild-type ex-Ldt Mt2 , even at concentrations in the millimolar range (data not shown). The BME disulfide adduct ( Figure 4B ) observed when protein samples are treated with BME interferes with imipenem and meropenem binding: the K D of these compounds increases an order of magnitude (data not shown).
b-Lactamase Activity of ex-Ldt Mt2
The kinetics of opening the lactam ring of imipenem by ex-Ldt Mt2 displays the expected irreversible inhibitor characteristics (Figures 7A and 7B) . The enzymatic reaction stops after one turnover. The ratio of the total amount of imipenem rings opened to the amount of enzyme added is close to one (0.96 ± 0.07, Figure 7B ).
To further characterize the enzyme, the b-lactamase activity of ex-Ldt Mt2 was measured using the chromogenic substrate nitrocefin as a reporter (O'Callaghan et al., 1972) . A low b-lactamase activity was observed, with a K M of 16 mM and a k cat of 0.01 s À1 ( Figure 7C ; Table S2 ). The pH profile of the reaction shows a maximum catalytic rate at pH 7.8 ( Figure 7D ; Table S3 ). The enzymatic reaction shows the biphasic kinetics observed before in b-lactamases (Figures 7E and 7F ). An initial burst of activity Structure Structure of Mtb Ldt Mt2 ( Figure 7E ) is followed by a linear slower rate (k deacylation , 33.4 nM/min; Figure 7F ), characteristic of a bifurcated kinetic path consistent with the formation of an alternative, more labile, acyl-enzyme intermediate species (Monks and Waley, 1988) .
Two pieces of evidence reduce the possibility that contamination with b-lactamases from the bacterial expression host is the source of the weak activity observed. First, the C354A mutant of ex-Ldt Mt2 expressed and purified the same way as the wild-type shows no detectable b-lactamase activity (data not shown). Second, no inhibition of ex-Ldt Mt2 b-lactamase activity was detected with clavulanic acid (data not shown), which at the concentrations tested (tens of millimolars), should have inhibited most known bacterial b-lactamases.
DISCUSSION
The degree of crosslinking and proportion of each type of linkage in the peptidoglycan layer vary among different bacterial species as well as during different growth phases. For example, the degree of crosslinking of the E. coli peptidoglycan is approxi- mately 50%, with 4/3 linkages accounting for 95% (90% in stationary phase) of the linkages (Vollmer and Hö ltje, 2004) . In contrast, the degree of crosslinking of the Mycobacterium spp peptidoglycan is as high as 80%, with 3/3 linkages comprising 70% (80% in stationary phase) of total linkages (Matsuhashi, 1966) . This high frequency of 3/3 linkages in mycobacteria contrasts sharply with the low level commonly observed in most other bacteria. For example, in E. coli and E. faecium, 3/3 linkages represent only a relatively small fraction of the total: 5% during growth phases, and 10% in stationary phase (Tuomanen and Cozens, 1987) . During the stationary phase of growth, formation of new 4/3 linkages is impaired because the mature peptidoglycan layer has few pentapeptide stems, the required substrates of D,D-transpeptidases, and the de novo synthesis of precursors is significantly reduced (Goffin and Ghuysen, 2002) . In contrast, L,D-transpeptidases could still crosslink the available tetrapeptide donors.
Expression of the Mtb L,D transpeptidase Ldt Mt1 is upregulated in the transcriptome of laboratory models of persisters (Betts et al., 2002; Keren et al., 2011) and shows a 17-fold increase during the activation of the dormancy regulon of Mtb (Lavollay et al., 2008) . Interestingly, in all growth phases of Mtb, expression of Ldt Mt2 is 10-fold higher than that of Ldt Mt1 (Gupta et al., 2010) . These data underscore the importance of L,D-transpeptidase activity as a chemotherapeutic target.
Structural Comparison with Other L,D-Transpeptidases
The structure determined here shows that the bulk of the exLdt Mt2 CD (251-379 aa) has a fold similar to those of the C-terminal domain of B. subtilis ykuD (Bielnicki et al., 2006) (Figure 8 ). YkuD shows a small N-terminal domain with a fold, LysM, that is associated with cell wall degradation (Bateman and Bycroft, 2000) . The Ldt fm stalk domain is a 60-Å -long cylinder formed by a four a helix bundle, with each helix of the bundle connected by a small two-strand antiparallel b sheet ( Figure 8A ). The relative orientation of the two domains of Ldt fm is maintained by a long loop that follows the third a helix of the stalk domain resulting in an 82-Å -long cylindrical molecule ( Figure 8A ). In contrast, the orientation of the two domains of ex-Ldt Mt2 is maintained by direct interaction of residues of the CTSD with residues of the IgD, resulting in a maximum dimension of only 60 Å ( Figure 8A ).
The solvent accessibility of the catalytic site is very different in these three bacterial enzymes: ykuD shows a completely open site, whereas Ldt Mt2 and Ldt fm show a site cover by the b-hairpin flap ( Figure 8B ). The b-hairpin flap of Ldt Mt2 is similar to that of Ldt fm , although it has a seven-residue longer loop L F that narrows the inner cavity of Ldt Mt2 . The catalytic site of ykuD shows the greatest divergence of the three sites ( Figure 8C ). Although these three enzymes preserve a similar arrangement of the catalytic triad residues, most of the Ldt Mt2 and Ldt fm catalytic site residues are conserved with only a few changes that (nevertheless) maintain the overall shape of the site ( Figure 8C ).
Mtb Ldt Mt2 Homologs
Comparative modeling of Ldt Mt2 homologs in Mtb predicts localized variations in their IgD and CD that may perturb the IgD-CD interaction. Loop modifications at the interface between the IgD and CD, and the loss of CTSD interaction with the IgD (Figure 3A) , could change each enzyme's overall shape and flexibility. It is worth noting that these homologs are membraneassociated proteins and have different levels of expression during different phases of growth (Gupta et al., 2010) . Their different shape and flexibility could reflect the fact that these enzymes are specialized to target different peptidoglycan layer constituents, act at different levels in the three-dimensional peptidoglycan layer (Vollmer and Hö ltje, 2004) , or form a particular crosslinking pattern by acting only on stems that present a Table S1 for the C354A mutant structure determination statistics.
spatial arrangement that is optimum for a given enzyme. These multiple enzymes may provide a mechanism for modulating the three-dimensional structure of the peptidoglycan layer during different phases of growth.
Binding of Imipenem to Ldt Mt2
The shape of the binding isotherm indicates the presence of equilibrium between bound and unbound species ( Figure 5C ). Kinetic experiments using fluorescence and absorption spectrophotometric techniques to follow the inactivation by imipenem of two closely related enzymes, Ldt fm (Triboulet et al., 2011) and Ldt Mt1 (Dubé e et al., 2012) , showed the presence of an enzyme-inhibitor complex before the irreversible acylation. Such complex is consistent with the apparent tight binding of imipenem to Ldt Mt2 we observed using ITC (K D = 54.8 ± 8.8 nM). The observation of a tight complex enzyme inhibitor previous to enzyme-irreversible acylation, the one-to-one relation between inactivated enzyme and consumed inhibitor ( Figures 7A and 7B) , and the lack of binding of the inhibitor to the catalytically inactive C354A mutant suggest that the formation of a reversible tetrahedral intermediate (see below) is required for a strong binding of imipenem to Ldt Mt2 .
Ldt Mt2 Catalytic Mechanism
Biarrotte-Sorin et al. (2006) proposed that in this kind of L,Dtranspeptidase, the two paths to the catalytic cysteine (via the inner or the outer cavity; Figure 1C ) are used one for the acyl donor and the other for the acyl-acceptor substrates. However, in this mechanism, the enzyme would need to go through multiple conformational changes of the flap to accommodate entrance of substrates and release of products using the catalytic site tunnel. The mode of binding of the peptidoglycan fragment found in the structure of Ldt Mt2 suggests a much simpler mechanism, in which the acyl-donor peptidoglycan stem binds to both cavities through the tunnel ( Figures  1C and 4) and remains bound during most of the catalytic cycle, reducing the need for conformational changes during the catalytic cycle of the enzyme. We built models of the peptidoglycan stem substrates bound to the active site of the enzyme based on the structure of Ldt Mt2 and use it to propose atomic details of the catalytic mechanism of Ldt Mt2 (Figure 9 ). In this model, the catalytic site tunnel and features at either Tables S2 and S3. side of the tunnel tightly bind the stem diamino acid (A 2 pm 3 ).
At one end of the tunnel, within the inner cavity, Tyr318 and the carbonyl group of Gly332 recognize the D chiral center of the diamino acid side chain, making H bonds to its carboxylate and amide group. The tunnel recognizes the aliphatic portion of the side chain. At the other end, within the outer cavity, the L chiral center is surrounded by an ''anion hole'' formed by the backbone NH group of residues 352-354 at the C terminus of loop Lc. In this position, the acyl group of the m-A 2 pm 3 L chiral center is within reach of Cys354. These features are consistent with a nucleophilic attack by this cysteine on the acyl carbon. In the crystal structure of ex-Ldt Mt2 , the Sg atom of Cys354 points toward the inside entrance of the catalytic site, away from the putative acyl group. Identical cysteine conformations (c y À73 ) have been consistently observed in all the other crystal structures of ErfK/YbiS/ YhnG domain proteins (Biarrotte-Sorin et al., 2006; Bielnicki et al., 2006) . Therefore, one can expect that earlier in the catalytic cycle, the cysteine may adopt another conformation (c y 58
) that points toward the carbonyl carbon of the scissile bond. In this conformation, the SH group would be briefly at 2.9 Å from the Nε atom of His336, allowing deprotonation of the Cys354 SH group for the nucleophilic attack at the peptide carbonyl group. The imidazolium cation of the protonated His336 may then be the donor for the protonation of the departing D-Ala amide. His336 and Asn356 make H bonds to this CO group, providing further recognition of the donor stem L chiral center ( Figure 4A ). The pH dependence of the reaction rate shows an increase of b-lactamase activity compatible with the ionization of a group with a pKa of around 7.8 ( Figure 6D ; Table S3 ). Participation of the Cys354-thiolate/His336-imidazolium ion pair in the concerted acid base catalysis of the acyl transfer is compatible with this pH optimum.
The rest of the interactions between the Ldt Mt2 and the bound peptidoglycan fragment involves the side chain of Asn356, which coordinates the main-chain NH group and the terminal carboxylate of D-Ala 4 (D-Ala 4 binding site). Trp340 provides steric constraints to the stem terminus that may explain the preference of the enzyme for tetrapeptide stems (Lavollay et al., 2008) . Interestingly, in one of the Mtb homologs of Ldt Mt2 , MT0501, a less bulky methionine residue replaces Trp340 ( Figure 3B ), suggesting that this enzyme can accommodate pentapeptides, perhaps broadening its specificity from D-Ala to noncanonical D-amino acids observed by Cava et al. (2011) . Toward the N terminus of the peptidoglycan stem, the conserved His352 provides a H bond to groups of the isoglutamyl side chain.
In the observed tautomer, forced by the H bond to the carbonyl of Ser337, His336 has its Nε ready to accept a H + from Cys354 Figure 9A, step 4) . Nucleophilic attack by this amine group forms the new peptide bond that crosslinks the two stems with release and protonation of the cysteine thiolate by His336 (Figure 9 , steps 5 and 6). It is clear that the last step in the transpeptidation reaction requires that donor and acceptor peptidoglycan stems both be at the catalytic site for the reaction to occur ( Figure 9B ). The wide and shallow entrance of the outer cavity has the required characteristics to accommodate both peptidoglycans stems ( Figure 9B ).
Higher-order crosslinked stems are also observed in Mtb, though with low frequency (3%) (Lavollay et al., 2008) , suggesting that already-linked peptidoglycan stems are not precluded from participating in new crosslinks. Linked stems can dock in the vestibule with their unreacted D chiral center reaching the catalytic residues without any conformational change in the enzyme. The use of the unreacted L chiral center of an already-crosslinked stem as acyl donor imposes more steric constraints and most likely involves the opening of the flap. After formation of the new crosslink, release of the higher-order linked peptide stems will require opening the flap again.
Conclusions
The crystal structure of the complex of an Mtb L,D-transpeptidase with a peptidoglycan fragment reported here provides a three-dimensional map of the extensive interactions between the peptidyl stem and Ldt Mt2 , involving residues that are conserved in all members of this Mtb family of L,D-transpeptidases. Knowing this map is an important step toward a rational design of high-affinity drugs engineered to inhibit L,D-transpeptidase activity.
EXPERIMENTAL PROCEDURES
Protein Preparation, Purification, and Crystallization A truncated construct of MT2594 (Rv2518c) spanning residues 120-408 (exLdt Mt2 ) was expressed in E. Coli BL21(DE3) strains and in a methionine auxotroph strain supplemented with SeMet. Proteins were separated from the lysates using (Ni)-affinity chromatography (Ni-HisTrap; GE Healthcare). Size exclusion chromatography was performed using a Sepharose column (Sepharose 12; GE Healthcare). Native and SeMet-derivatized protein samples were used in the crystallization trials. Diffraction quality crystals of all forms used in this study were obtained in 48 hr at 20 C with hanging drop vapor diffusion methods. Drops of 1ml of protein (20 mg/ml) and 1 ml of reservoir solution were equilibrated against a reservoir containing 0.1 M HEPES (pH 7.5), 1 M succinic acid, and 1% (w/v) PEG MME 2000, except for SeMet crystals in which HEPES at pH 7.0 was used. For heavy-atom derivates, crystals were soaked in 10 ml of reservoir solution containing the heavy-atom compounds at the desired concentration. In the case of PIP, ex-Ldt Mt2 crystals were soaked with 100 mM for 48 hr. See Supplemental Experimental Procedures for additional details.
Data Collection, Structure Determination, and Refinement Diffraction data of the PIP derivative, mutant, and BME disulfide adduct and oxidized forms of the native were collected using an in-house CuKa X-ray source (FR-E+ SuperBright generator with a Saturn 944+ CCD Detector; Rigaku, The Woodlands, TX, USA). The SeMet-derivative crystal used in the phase determination was collected on beamline X4A of the National Synchrotron Light Source of the Brookhaven National Laboratory (Table 1) . X-ray diffraction experiments were carried out under cryogenic conditions after transferring the crystal into crystallization solution containing 10% v/v glycerol. Intensities were indexed and integrated using HKL2000 (HKL Research). Data were scaled with the CCP4 program suite (Collaborative Computational Project, Number 4, 1994) . Phases were determined using the program autoSHARP (Vonrhein et al., 2007) . Refinement was carried out using REFMAC5 (Murshudov et al., 2011) , and rebuilding was done with Coot (Emsley and Cowtan, 2004) .
Calorimetric Studies
ITC experiments were performed using a high-precision VP-ITC titration calorimeter system (MicroCal Software, Northampton, MA, USA). The buffer of the protein samples was replaced by 20 mM HEPES, 300 mM NaCl (pH 7.5) using a desalting column (HiTrap G-25; GE Healthcare). Inhibitors and substrates used in these experiments were dissolved in the same buffer. ITC experiments using PBS and PIPES showed similar DH values, indicating that no H + s were released or bound during the reaction. Titration experiments consisted of the addition of 25 injections of 10 ml of concentrated inhibitor into the protein solution contained in the cell (1.38 ml) with 300-450 s equilibration between injections. Data were analyzed with Origin 5.0 software (MicroCal) with a single-site model. Imipenem monohydrate and meropenem were purchased from Sigma-Aldrich.
Enzyme Kinetics
Initial rate measurements were used to determine the steady-state kinetic parameters of the b-lactamase activity against nitrocefin-3-(2,4-Dinitrostyryl)-(6R, 7R)-7-(2-thienylacetamido)-ceph-3-em-4-carboxylic acid, EMD ( Figure 7D )-a chromogenic b-lactam. The b-lactamase activity was measured by following the absorbance of the product produced by opening the lactam ring at 486 nm using a molar extinction coefficient of 20,500 M À1 cm À1 (O'Callaghan et al., 1972) in metal-free buffer of 20 mM HEPES (pH 7.5) and 300 mM NaCl. Nitrocefin was added at concentrations ranging from 12.5 to 200 mM. The kinetic parameters, K M , and k cat were fitted by a nonlinear least-squares fit of Michaelis-Menten equation to the initial rate measurements. Enzyme acylation by imipenem was measured by quantifying the amount of reacted imipenem at a given time, following the formation of the open penem ring product by monitoring the absorbance at 299 nm. The decrease in absorbance values was converted into concentration units using the difference between molar extinction coefficients of the open and closed penem ring of À7,100 M À1 cm À1 (Triboulet et al., 2011) .
ACCESSION NUMBERS
The PDB accession numbers for the coordinates and structure factors of ex-Ldt Mt2 , C354A mutant, BME-adduct, and oxidized forms reported in this paper are 3TUR, 3TX4, 3U1P, and 3VAE.
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